Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-bupivacaine versus ketamine-bupivacaine preemptive wound infiltration for postoperative pain after lower abdominal surgery
IRCT20090129001615N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine, bupivacaine and ketamine in postoperative pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of postoperative pain, Time to first analgesia and 1 more. Started Sep 2023; status: completed.
02
Drugs
dexmedetomidinebupivacaineketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20090129001615N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090129001615N9.